GGrantIndex
← Search

DLA Pharmaceutical Prime Vendor (PPV) Program

$668,619Y01FY2022AINIH

National Institute Of Allergy And Infectious Diseases

Investigators

Abstract

The PPV contract enables DAIT/ NIAID to purchase brand name pharmaceutical products (ie: biologics) at a significantly discounted (50-60% cheaper) price for clinical trials where the institute holds the IND.

View original record on NIH RePORTER →